Pharma USFDA Warning Letter for Alkermes, Inc.

Pharmaceutical Guidanace April 14, 2020 USFDA WARNING LETTER Comments Off on Pharma USFDA Warning Letter for Alkermes, Inc. 759 Views

Alkermes, Inc. MARCS-CMS 597260 —

For Warning Letter Click Here –  

  • Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.

Image result for usfda warning letter

For more USFDA warning Letter Visit :https://pharmaguidances.com/shop/guideline/usfda-warning-letter/

A 9 -

A 7 -

A 8 -

About Pharmaceutical Guidanace

Mr. Shiv Kumar is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 14 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

A 15 -

Pharma USFDA Warning Letter for Derma Pharm A/S MARCS-CMS

Teligent Pharma, Inc. MARCS-CMS 587592 — November 26, 2019 For Warning Letter Click Here –   …

Designed by Pharmaguidances
© Copyright 2023, All Rights Reserved
error: Content is protected !!